TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/18/24 20:22 | 1/18/24 | RGLS | Regulus Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | CEO | S | -17 | 1.19 | 0 | -15 | -20 | 57 | D | ||||||||||||||
5/23/23 17:18 | 5/18/23 | AUPH | Aurinia Pharmaceuticals Inc. | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | A0 | D | M.d | 0 | 0.00 | 0 | 9 | 271 | 12 | D | ||||||||||||||||
5/23/23 17:18 | 5/19/23 | AUPH | Aurinia Pharmaceuticals Inc. | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | A0 | D | S.d | -3 | 10.58 | 0 | 0 | -2 | 12 | D | ||||||||||||||||
1/26/22 16:13 | 1/26/22 | RGLS | Regulus Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | P.d | 22 | 0.2152 | 0 | 100 | 32 | 417 | D | ||||||||||||||
1/4/22 16:17 | 1/3/22 | AUPH | Aurinia Pharmaceuticals Inc. | A0 | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | A1 | D | M.d | 203 | 5.08 | 0 | 40 | 4 | D | ||||||||||||||||
1/4/22 16:17 | 1/3/22 | AUPH | Aurinia Pharmaceuticals Inc. | A0 | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | A1 | D | S.d | -904 | 22.59 | 0 | -40 | -92 | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |